Moderna Gains 7% as Cowen Upgrades MRNA Stock from Market Perform to Outperform
Along with noting that Moderna will lead the RSV vaccine market, Cowen additionally referred to main opinion leaders’ perception within the pharmaceutical firm competing in a “three-player vaccine market”. Shares….